News: Portfolio 2007

Renal Solutions, Inc. Announces Acquisition by Fresenius Medical Care

(continued)

“The convergence of our respective resources will enhance the prospects for true innovative approaches, including portability and wearability, to further improve the service to patients requiring dialysis therapy worldwide.”

 

RSI is currently commercializing the Allient® Sorbent Hemodialysis System for chronic and acute hemodialysis applications. The Allient System will be the first dialysis system to bring SMARRT technology to the market, opening new treatment options to dialysis professionals and patients.

 

The current RSI home use clinical study featuring the Allient System and sorbent technology will continue enrollment at multiple sites.

 

 

The trial is designed to demonstrate patient ability to self-administer hemodialysis in the home using the FDA cleared system. In this research study, 25 dialysis participants will self-administer extended duration dialysis in the home. 

 

Morgan Stanley served as advisor to Renal Solutions for the transaction.

 

About Renal Solutions, Inc

Renal Solutions, Inc., a medical device and healthcare service company, is commercializing the Allient® Sorbent Hemodialysis System, a revolutionary technology/service solution for the chronic and acute dialysis market. The Allient System, brings SMARRT (Sorbent Management for Advanced Renal Replacement Therapy) therapy to the dialysis field, opening new treatment options to dialysis professionals and patients by virtue of its ability to provide short, standard or extended duration hemodialysis therapy using just 1 and 1/2 gallons of ordinary drinking water. Numerous clinical studies have shown that an increased cumulative dialysis dose results in better patient outcomes.

 

Page: 1 2 3